scispace - formally typeset
E

Ellen M. Mowry

Researcher at Johns Hopkins University

Publications -  161
Citations -  9853

Ellen M. Mowry is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 35, co-authored 132 publications receiving 6579 citations. Previous affiliations of Ellen M. Mowry include Johns Hopkins University School of Medicine & University of Southern California.

Papers
More filters
Journal ArticleDOI

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

TL;DR: The 2017 McDonald criteria continue to apply primarily to patients experiencing a typical clinically isolated syndrome, define what is needed to fulfil dissemination in time and space of lesions in the CNS, and stress the need for no better explanation for the presentation.
Journal ArticleDOI

Incidental mri anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

TL;DR: Individuals with MRI anomalies highly suggestive of demyelinating pathology, not better accounted for by another disease process, are very likely to experience subsequent radiologic or clinical events related to multiple sclerosis.
Journal ArticleDOI

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.

TL;DR: It is found that vitamin D status, a risk factor for multiple sclerosis, is associated with the rate of subsequent clinical relapses in pediatric‐onset multiple sclerosis.
Journal ArticleDOI

Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

TL;DR: Compared with the other groups, untreated patients with multiple sclerosis had an increase in the Akkermansia, Faecalibacterium, and Coprococcus genera after vitamin D supplementation.
Journal ArticleDOI

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.

TL;DR: This work sought to determine whether vitamin D status is associated with developing new T2 lesions or contrast‐enhancing lesions on brain magnetic resonance imaging (MRI) in relapsing multiple sclerosis (MS).